Supply Chain Considerations (Temperature, Chain of Identity, Chain of Custody, Scalability, Regulations for Transport)

By the end of this session, attendees will be able to:

  • List two (2) major strategies employed for delivering a robust personalized medicine supply chain
  • Identify at least two (2) concerns in the handling of cell and gene therapy clinical materials
  • Describe potential labeling solutions appropriate to the labeling of cell and gene therapy products for transport
  • Create better outcomes for patients via the creation of a robust supply chain

Login

Please log in using your GCSG credentials.

Lost your password?

Login

Please log in using your GCSG credentials.

Lost your password?